An Introduction to Rare Diseases
Rare autoimmune diseases are a heterogeneous group of conditions that are challenging for both clinician and patient as they are difficult to diagnose and there is a lack of knowledge of individual conditions. Many such conditions exist; some of the most well characterised include eosinophilic granulomatosis with polyangiitis, Guillain-Barre syndrome, Kawasaki disease, mixed connective tissue disease, myasthenia gravis, myositis, paroxysmal nocturnal haemoglobinuria, POEMS syndrome, retroperitoneal fibrosis, scleroderma and thyroid eye disease. A further challenge is the lack of approved therapies. Advances in understanding of the molecular, immunological and genetic basis of autoimmune diseases has elucidated novel therapeutic approaches, but many knowledge gaps remain.
Expert video highlights and insights from the conference hub and comprehensive peer-reviewed articles from our journal portfolio provide updates on the changing treatment landscape. To learn more about how the latest developments impact on patient outcomes view our expert-led learning activities.
Our supporting partners do not constitute an endorsement of the content on this page.
Rare Diseases Content
Achieving best practice management of primary biliary cholangitis, now and in the future
Watch two specialists in autoimmune liver disease discuss best practice in the management of primary biliary cholangitis, including assessing emerging therapies and personalization of care.
- Describe the recommendations for diagnosis and management of patients with primary biliary cholangitis
- Evaluate emerging treatment options for patients with primary biliary cholangitis
- Review and implement individualized management for patients with primary biliary cholangitis
Emanuel Della Torre, EASL ILC 2021: IgG4-related Systemic Disease Treatment
touchIMMUNOLOGY caught up with Dr Emanuel Della Torre (Università Vita-Salute San Raffaele Unit of Immunology, Rheumatology, Allergy, and Rare Diseases, Ospedale San Raffael, Milan, Italy) to discuss the current and future treatment of immunoglobulin G4-related (IgG4) diseases. His presentation entitled ‘Management: current therapy of IgG4-related systemic disease and what is on the horizon‘ was given […]
Journal articles and more to your inbox
Get the latest clinical insights from touchIMMUNOLOGYSign me up!